Variable association of atypical femur fracture and osteonecrosis of jaw with bisphosphonates and denosumab use: Drug-safety surveillance study

Tigran Makunts, Lara S. Anwar, Ruben Abagyan
doi: https://doi.org/10.1101/2020.06.15.20132290

Article Information

doi 
https://doi.org/10.1101/2020.06.15.20132290
History 
  • June 17, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Tigran Makunts1,2,
  2. Lara S. Anwar1 and
  3. Ruben Abagyan1,*
  1. 1University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego, California, United States
  2. 2Oak Ridge Institute of Science and Education Fellowship, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland, United States
  1. ↵* Corresponding author (RA) e-mail: rabagyan{at}health.ucsd.edu
Back to top
Posted June 17, 2020.
Download PDF
Data/Code
Email
Variable association of atypical femur fracture and osteonecrosis of jaw with bisphosphonates and denosumab use: Drug-safety surveillance study
Tigran Makunts, Lara S. Anwar, Ruben Abagyan
medRxiv 2020.06.15.20132290; doi: https://doi.org/10.1101/2020.06.15.20132290
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area